Table 2 Antimicrobial resistance in Polish ICUs by VAP, 2013–2015
Number of isolates | Antibiotic or resistant codes | Non susceptible N (%) | |
|---|---|---|---|
Gram-positive cocci | |||
Staphylococcus aureus | 27 | MRSA | 2 (7.4) |
ampicillin | 0 (0) | ||
glycopeptides | 0 (0) | ||
Enterobacteriaceae | |||
Escherichia coli | 12 | ampicillin | 7 (58.3) |
ceftazidime | 3 (25.0) | ||
cefotaxim/ceftriaxone | 3 (25.0) | ||
imipenem | 1 (8.3) | ||
meropenem/doripenem | 0 (0) | ||
ESBL | 1 (8.3) | ||
Klebsiella pneumoniae | 31 | ampicillin | 28 (90.3) |
ceftazidime | 22 (71.0) | ||
cefotaxim/ceftriaxone | 23 (74.2) | ||
imipenem | 0 (0) | ||
meropenem/doripenem | 0 (0) | ||
ESBL | 15 (48.4) | ||
Non-fermenting Gram-negative bacteria | |||
Acinetobacter baumannii. | 34 | imipenem | 24 (70.6) |
meropenem/doripenem | 18 (52.9) | ||
colistin | 0 (0.0) | ||
sulbactam | 14 (41.2) | ||
Pseudomonas aeruginosa | 10 | piperacillin | 2 (20.0) |
ceftazidime | 2 (20.0) | ||
colistin | 0 (0.0) | ||
imipenem | 2 (20.0) | ||
meropenem/doripenem | 2 (20.0) | ||